ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Thyroid Cancer · Prognosis & follow-up

What is the prognosis for thyroid cancer?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Thyroid Cancer Answer length: short, citable
Quick answer

Differentiated papillary and follicular thyroid cancer generally has excellent outcomes; five-year survival for localised papillary cancer is commonly reported above 98%, and even regional disease has high survival. Medullary carcinoma has an intermediate outlook, while anaplastic carcinoma is aggressive with short survival. Age, size, extrathyroidal extension, nodal burden, distant metastasis and histology drive individual risk.

In detail

Published survival figures are population averages from registry data. Your own outlook depends on stage, HPV or EBV status, margins, nodal involvement, general health, smoking status during treatment and response to the first treatment.

Most recurrences occur within the first two to five years. Follow-up visits are frequent at first (every one to three months in year one) and become annual after year five, in line with NCCN survivorship guidance.

What this means in practice: this answer is part of the “Prognosis & follow-up” section of the Thyroid Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about thyroid cancer

See all 14 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  2. Global Cancer Facts & Figures, 5th Edition (GLOBOCAN 2022 tables) American Cancer Society · 2024
  3. Thyroid cancer in Asia: incidence, mortality in 2022, and future projections to 2050 European Journal of Cancer Prevention · 2026 · South Korea had the highest ASR in Asia: 7.6/100,000 in men and 39.5/100,000 in women.
  4. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  5. Thyroid Cancer (patient information) US National Cancer Institute · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionWhat are the treatment options for thyroid cancer? Next question →Can thyroid cancer be prevented?

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.